205
Views
13
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Invasive fungal sinusitis: An effective combined treatment in five haematological patients

, , , , , , , , & show all
Pages 1577-1586 | Received 15 Jan 2007, Accepted 16 May 2007, Published online: 01 Jul 2009

References

  • Denning D W. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–805
  • DeShazo R D, Chapin K, Swain R E. Fungal sinusitis. N Engl J Med 1997; 337: 254–259
  • Marr K A, Carter R A, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917
  • Spellberg B, Edwards J, Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation and management. Clin Microbiol Rev 2005; 18: 556–569
  • Denning D W. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608–615
  • Lin S J, Schranz J, Teutsch S M. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366
  • Gleissner B, Shilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with haematological disease?. Leuk Lymphoma 2004; 45: 1351–1360
  • Greenberg R N, Scott L J, Vaughn H H, Ribes J A. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17: 517–525
  • Nucci M. Emerging moulds: fusarium, scedosporium and zygomicetes in transplant recipients. Curr Opin Infect Dis 2003; 16: 607–612
  • McLean F M, Ginsberg L E, Stanton C A. Perineural spread of rhinocerebral mucormycosis. Am J Neuroradiol 1996; 17: 114–116
  • Silverman C S, Mancuso A A. Periantral soft-tissue infiltration and its relevance to the early detection of invasive fungal sinusitis: CT and MR findings. Am J Neuroradiol 1998; 19: 321–325
  • Rizk S S, Kraus D H, Gerresheim G, Mudan S. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients. Ear Nose Throat J 2000; 79: 278–285
  • Marple B F. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001; 111: 1006–1019
  • Ascioglu S, Rex J S, de Pauw B, Bennet J E, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14
  • Mantovani M, Guastella C, Mazzola R. The Guastella/Mantovani septal – valve splint, an intranasal biplanar and multivectorial orthopedic device. Plast Reconstr Surg 2000; 106: 475–478
  • Bohme A, Runhnke M, Buchheidt D, Karthaus M, Einsele H, Guth S, et al. Treatment of fungal infections in hematology and oncology. Ann Hematol 2003; 82(Suppl 2)S133–S140
  • Herbrecht R, Denning D W, Patterson T F, Bennett J E, Greene R E, Oestmann J -W, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New Engl J Med 2002; 347: 408–415
  • Herbrecht R, Nivoix Y, Fohrer C, Natarajan-Ame S, Letscher-Bru V. Management of systemic fungal infections: alternatives to itraconazole. J Antimicrob Chemother 2005; 56(Suppl S1)i39–i48
  • Zinreich S J, Kennedy D W, Malat J, Curtin H D, Epstein J I, Huff L C, et al. Fungal sinusitis: diagnosis with CT and MR imaging. Radiology 1988; 169: 439–444
  • Som P M, Dillon W P, Curtin H D, Fullerton G D, Lidov M. Hypointense paranasal sinus foci: differential diagnosis with MR imaging and relation to CT findings. Radiology 1990; 176: 777–781
  • Walsh T J, Teppler H, Donowitz G R, Maertens J A, Baden L R, Dmoszynska A, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004; 351: 1391–1402
  • Klastersky J, Paesmans M. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Support Care Cancer 2007; 15: 137–141
  • Potter M. Strategies for managing systemic fungal infection and the place of itraconazole. J Antimicrob Chemother 2005; 56(Suppl 1)i49–i54
  • Patterson T F, Boucher H W, Herbrecht R, Denning D W, Lortholary O, Ribaud P, et al. European Organization for Research and Treatment of Cancer EORTC) Invasive Fungal Infections Group (IFIG); Pfizer Global Aspergillus Study Group. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin Infect Dis 2005; 41: 1448–1452
  • Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez J A, Teppler H, et al. Efficacy of caspofungin against invasive candida or invasive aspergillus infections in neutropenic patients. Cancer 2006; 106: 466–473
  • Maertens J, Glasmacher A, Herbrecht R, Thiebaut A, Cordonnier C, Segal B H, et al. Caspofungin Combination Therapy Study Group. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 2006; 107: 2888–2897
  • Ellis M, Frampton C, Joseph J, Alizadeh H, Kristensen J, Hauggaard A, et al. An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy. J Med Microbiol 2006; 55: 1357–1365
  • Safdar A, Hanna H A, Boktour M, Kontoyiannis D P, Hachem R, Lichtiger B, et al. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of candida species bloodstream infections. Cancer 2004; 101: 2859–2865
  • Mousset S, Hermann S, Klein S A, Bialleck H, Duchscherer M, Bomke B, et al. Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia. Ann Hematol 2005; 84: 734–741
  • Dignani M C, Anaissie E J, Hester J P, O'Brien S, Vartivarian S E, Rex J H, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 1997; 11: 1621–1630
  • Anselmo-Lima W T, Lopes R P, Valera F C, Demarco R C. Invasive fungal rhinosinusitis in immunocompromised patients. Rhinology 2004; 42: 141–144
  • Iwen P C, Rupp M E, Hinrichs S H. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997; 24: 1178–1184
  • Singer M S, Seibel N L, Vezina G, Choi S S, Dinndorf P A. Successful treatment of invasive aspergillosis in two patients with acute myelogenous leukemia. J Pediat Hematol Oncol 2003; 25: 252–256
  • Hopkins C, Browne J P, Slack R, Lund V J, Topham J, Reeves B P, et al. Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a national audit in England and Wales. Laryngoscope 2006; 116: 1494–1499
  • Hopkins C, Browne J P, Slack R, Lund V J, Topham J, Reeves B P, et al. The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Clin Otolaryngol 2006; 31: 390–398
  • Dessi P, Castro F, Triglia J M, Zanaret M, Cannoni M. Major complications of sinus surgery: a review of 1192 procedures. J Laryngol Otol 1994; 108: 212–215
  • Wang P C, Chu C C, Liang S C, Tai C J. Outcome predictors for endoscopic sinus surgery. Otolaryngol Head Neck Surg 2002; 126: 154–159
  • Ponikau J U, Sherris D A, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005; 115: 125–131
  • Piatti G, Scotti A, Ambrosetti U. Nasal ciliary beat after insertion of septo-valvular splints. Otolaryngol Head Neck Surg 2004; 130: 558–562
  • Kennedy C A, Adams G L, Neglia J P, Scott Giebink G. Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients. Otolaryngol Head Neck Surg 1997; 116: 610–616

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.